Body weight showed a mean percentage of variation from the start to the end of the study of 4.2%, weight gain greater than 7% was reported in 4% of patients, increased prolactin levels in 9% (without related symptoms), dyskinesia in 4%, sexual dysfunction in 4%, and sedation in 14% during the first day after the injection. Here, PRL is linked to drug-induced dyskinesia.